ArticleBMC microbiology2025
Endophytic actinobacteria from Mentha longifolia and Lonicera nummulariifolia: a novel source against antibiotic resistance.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A novel Umezawaea tangerina endophyte reveals anti-colorectal cancer activity and a rich biosynthetic landscape.Scientific reports · 2026Article
- Isolation, Screening, and Characterization of Gordonia paraffinivorans DGM-81 Exhibiting Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA).Current microbiology · 2026Article
- Polyphasic characterization, bioactive potential and metabolite profiling of Streptomyces violaceoruber R6 isolated from Ocimum tenuiflorum.BMC microbiology · 2026Article
- Endophytic actinomycetes as a reservoir of novel chemotherapeutic leads against multidrug-resistant cancer.Frontiers in artificial intelligence · 2026Article
- Antibacterial Activity of Metabolites of EndophyticInternational journal of microbiology · 2025Article
- Unlocking plant growth-promoting traits of endophytic actinobacteria isolated fromFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe escalating global challenge of antibiotic resistance severely restricts our ability to treat common infectious diseases, necessitating the urgent need for the development of novel antibiotics with distinct mechanisms of action. Actinobacteria, a diverse group of bacteria with medical, industrial, pharmaceutical, and ecological significance, produce approximately two-thirds of clinically used antibiotics. Endophytic actinobacteria (EA), residing within various plant species, represent a promising source for discovering novel antibiotics to combat this raising threat. This study aimed to explore the diversity and antibacterial characteristics of EA isolated from Mentha longifolia and Lonicera nummulariifolia, leveraging the host specificity and adaptation of EA to different plant species. Healthy plant samples were surface-sterilized and cultured on four distinct isolation media.
resultsNine EA isolates were identified from the roots, stems, and leaves of the plants based on morphological and molecular characterization. These isolates were taxonomically classified into two different families, Nocardiaceae and Streptomycetaceae, with Streptomyces being the dominant genus. All strains, except KUMS-B13, were reported as endophytes for the first time. Among the isolates, KUMS-B9 showed 98.66% sequence similarity to its closest relative strain, classifying it as a potential rare novel strain. The isolates exhibited diverse spore morphologies, including cylindrical, cubic, biconvex, oval, or ovoid shapes, with smooth or wrinkled surfaces. Six of the nine isolates displayed antibacterial activity against at least one of the tested bacteria: Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. Isolate KUMS-B11, closely related to Streptomyces flavogriseus, showed broad-spectrum inhibition against all tested bacteria. Notably, a majority of the isolates demonstrated antagonistic activity against P. aeruginosa.
conclusionsThis study highlights EA isolated from Mentha longifolia and Lonicera nummulariifolia as a valuable source of medically bioactive metabolites with potential applications in human health. The isolation of new EA presents a promising approach to discovering novel therapeutic agents from unexplored ecological niches to battle antibiotic resistance. Furthermore, these findings emphasize the potential of plant-symbiotic bacteria in producing bioactive compounds with significant medicinal, pharmaceutical, and biotechnological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.